Rhalena A. Thomas

1.1k total citations · 1 hit paper
20 papers, 592 citations indexed

About

Rhalena A. Thomas is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Rhalena A. Thomas has authored 20 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Rhalena A. Thomas's work include Single-cell and spatial transcriptomics (4 papers), Pluripotent Stem Cells Research (4 papers) and Nerve injury and regeneration (4 papers). Rhalena A. Thomas is often cited by papers focused on Single-cell and spatial transcriptomics (4 papers), Pluripotent Stem Cells Research (4 papers) and Nerve injury and regeneration (4 papers). Rhalena A. Thomas collaborates with scholars based in Canada, France and United States. Rhalena A. Thomas's co-authors include Edward A. Fon, Mohamed A. Eldeeb, Mohamed A. Ragheb, Philip Barker, Reddy Peera Kommaddi, Claire Ceni, Thomas M. Durcan, Peter S. McPherson, Emily Vereker and Brigitte Ritter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Rhalena A. Thomas

17 papers receiving 588 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial quality control in health and in Parkinson’s disease

2022 162 citations Mohamed A. Eldeeb, Rhalena A. Thomas et al. Physiological Reviews profile →

Peers

Countries citing papers authored by Rhalena A. Thomas

Since Specialization

Citations

This map shows the geographic impact of Rhalena A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhalena A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhalena A. Thomas more than expected).

Fields of papers citing papers by Rhalena A. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhalena A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhalena A. Thomas. The network helps show where Rhalena A. Thomas may publish in the future.

Co-authorship network of co-authors of Rhalena A. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Rhalena A. Thomas. A scholar is included among the top collaborators of Rhalena A. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhalena A. Thomas. Rhalena A. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes 2025 ·npj Parkinson s Disease ·(unknown), Jialun Li, Edward A. Fon, Sali M.K. Farhan, Rhalena A. Thomas	0
2	ScRNAbox: empowering single-cell RNA sequencing on high performance computing systems 2024 ·BMC Bioinformatics ·Rhalena A. Thomas, (unknown), Saeid Amiri, Edward A. Fon, Sali M.K. Farhan	1
3	Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress 2024 ·Proceedings of the National Academy of Sciences ·Mohamed A. Eldeeb, Andrew N. Bayne, (unknown), Thomas Goiran, (unknown), (unknown), Cornelia E. Zorca, (unknown), Rhalena A. Thomas, (unknown), (unknown), Thomas M. Durcan, Jean‐François Trempe, Edward A. Fon	36
4	CelltypeR: A flow cytometry pipeline to characterize single cells from brain organoids 2024 ·iScience ·Rhalena A. Thomas, Julien Sirois, Shu-Ming Li, (unknown), (unknown), (unknown), (unknown), (unknown), Carol X.‐Q. Chen, Vincent Soubannier, (unknown), Lama Fawaz, Thomas M. Durcan, Edward A. Fon	0
5	Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing 2024 ·Molecular Neurobiology ·(unknown), Allison A. Dilliott, Rhalena A. Thomas, Sali M.K. Farhan	10
6	Machine learning nominates the inositol pathway and novel genes in Parkinson’s disease 2023 ·Brain ·Eric Yu, Roxanne Larivière, Rhalena A. Thomas, Lang Liu, Konstantin Senkevich, Shady Rahayel, Jean‐François Trempe, Edward A. Fon, Ziv Gan‐Or	9
7	Mitochondrial quality control in health and in Parkinson’s disease breakdown → 2022 ·Physiological Reviews ·Mohamed A. Eldeeb, Rhalena A. Thomas, Mohamed A. Ragheb, (unknown), Edward A. Fon	162
8	Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation 2021 ·Neurotherapeutics ·Omid Tavassoly, Esther del Cid‐Pellitero, (unknown), (unknown), Rhalena A. Thomas, Vincent Soubannier, Wen Luo, Thomas M. Durcan, Edward A. Fon	16
9	Auto-qPCR; a python-based web app for automated and reproducible analysis of qPCR data 2021 ·Scientific Reports ·Gilles Maussion, Rhalena A. Thomas, (unknown), (unknown), (unknown), Carol X.‐Q. Chen, Narges Abdian, (unknown), (unknown), (unknown), Lenore K. Beitel, Nicolás Ramoz, Philip Gorwood, Thomas M. Durcan	13
10	Standardized Quality Control Workflow to Evaluate the Reproducibility and Differentiation Potential of Human iPSCs into Neurons 2021 ·SSRN Electronic Journal ·Carol X.‐Q. Chen, Narges Abdian, Gilles Maussion, Rhalena A. Thomas, (unknown), (unknown), (unknown), Lenore K. Beitel, Jason Karamchandani, Edward A. Fon, Thomas M. Durcan	0
11	Generation of human midbrain organoids from induced pluripotent stem cells 2021 ·Nguyen‐Vi Mohamed, (unknown), (unknown), Rhalena A. Thomas, (unknown), Lenore K. Beitel, Edward A. Fon, Thomas M. Durcan	9
12	A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types 2021 ·Methods and Protocols ·Carol X.‐Q. Chen, Narges Abdian, Gilles Maussion, Rhalena A. Thomas, (unknown), (unknown), (unknown), Lenore K. Beitel, Jason Karamchandani, Edward A. Fon, Thomas M. Durcan	35
13	A molecular gradient along the longitudinal axis of the human hippocampus informs large-scale behavioral systems 2020 ·Nature Communications ·Jacob W. Vogel, Renaud La Joie, Michel J. Grothe, (unknown), Andrew Doyle, Étienne Vachon‐Presseau, Claude Lepage, Reinder Vos de Wael, Rhalena A. Thomas, Yasser Iturria‐Medina, Boris C. Bernhardt, Gil D. Rabinovici, Alan C. Evans	90
14	Weakly electric fish distinguish between envelope stimuli arising from different behavioral contexts 2018 ·Journal of Experimental Biology ·Rhalena A. Thomas, Michael G. Metzen, Maurice J. Chacron	6
15	The Nogo Receptor Ligand LGI1 Regulates Synapse Number and Synaptic Activity in Hippocampal and Cortical Neurons 2018 ·eNeuro ·Rhalena A. Thomas, Julien Gibon, Carol X.‐Q. Chen, Sabrina Chierzi, Vincent Soubannier, Stéphanie Baulac, Philippe Séguéla, Keith K. Murai, Philip Barker	13
16	The X‐linked inhibitor of apoptosis regulates long‐term depression and learning rate 2016 ·The FASEB Journal ·Julien Gibon, Nicolás Unsain, Karine Gamache, Rhalena A. Thomas, Andrés de León, (unknown), Karim Nader, Philippe Séguéla, Philip Barker	17
17	Identification of genetic variants of LGI1 and RTN4R (NgR1) linked to schizophrenia that are defective in NgR1–LGI1 signaling 2016 ·Molecular Genetics & Genomic Medicine ·Rhalena A. Thomas, Amirthagowri Ambalavanan, Guy A. Rouleau, Philip A. Barker	6
18	Trk‐dependent ADAM17 activation facilitates neurotrophin survival signaling 2011 ·The FASEB Journal ·Reddy Peera Kommaddi, Rhalena A. Thomas, Claire Ceni, (unknown), Philip Barker	32
19	LGI1 Is a Nogo Receptor 1 Ligand that Antagonizes Myelin-Based Growth Inhibition 2010 ·Journal of Neuroscience ·Rhalena A. Thomas, (unknown), José Manuel Morante‐Redolat, Madeline Pool, Christopher Kent, (unknown), (unknown), Gino B. Ferraro, (unknown), Yves Durocher, Alyson E. Fournier, Jordi Pérez‐Tur, Philip Barker	70
20	The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling 2010 ·Journal of Cell Science ·Claire Ceni, Reddy Peera Kommaddi, Rhalena A. Thomas, Emily Vereker, Xiaoyang Liu, Peter S. McPherson, Brigitte Ritter, Philip Barker	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact